← Open Payments lookup

LYDIA GREBE: Open Payments

NPI 1780788729 · COLUMBUS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,369 in 78 payments from 18 companies in 2025. Trend: 2023 $781 · 2024 $1,429 · 2025 $1,369

Food & beverage: $1,369
CompanyPaymentsAmount
Novo Nordisk Inc12$303
ABBVIE INC.23$256
Otsuka America Pharmaceutical, Inc.6$129
Astellas Pharma US Inc4$81
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$72
Lilly USA, LLC4$71
Bayer Healthcare Pharmaceuticals Inc.3$65
AstraZeneca Pharmaceuticals LP4$63
Lundbeck LLC3$56
Amgen Inc.3$50

Products named: VRAYLAR, Ozempic, REXULTI, Veozah, CAPLYTA, MOUNJARO, Kerendia, AIRSUPRA.

Industry payments across NJ — which companies pay providers there.